Pharmaceutical companies need to spend money in order to make money, and the looming loss of patent exclusivity for numerous products has these companies out in force striking business deals to fill ...

Pancreatic cancer is an aggressive disease with few available treatments. Thankfully, researchers are hard at work to improve treatment options, and researchers from Japan have now unveiled something ...

A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" by Rackear et al. was published in Oncotarget's Volume 15 on November 22, ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, recommending it as first-line therapy for folate receptor alpha–high ...

Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering ...

A look at cancer cells: Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby ...

Scientists have developed antibodies that block a common virus linked to cancer and autoimmune diseases from infecting immune ...

Bispecific antibodies have ushered in a transformative era in treating non–small cell lung cancer (NSCLC), enabling dual-pathway targeting with promising clinical outcomes in previously refractory ...

Scientists say they created a new type of antibody, which are tiny proteins produced by white blood cells to protect our body from bacteria or viruses. Cancer scientists say they have engineered a new ...